All In MedTech

Device Trial Radar · NCT07523204

Photobiomodulation Therapy for Scar Quality After Facial Wound Closure

Effect of Photobiomodulation Therapy (PBMT) on Scar Quality Following Traumatic Facial Wound Closure: A Prospective, Exploratory Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

41

Actual

Start

Oct 17, 2024

Primary completion

Oct 20, 2026

Study completion Oct 20, 2026

Sponsor

Lead sponsor
Hani M. Al-KufiAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 13, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 13 years, up to 47 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study tested whether photobiomodulation therapy (PBMT), a treatment that uses laser light, could improve scar quality after a facial injury. Participants whose wounds were closed with stitches were randomly assigned to receive either PBMT or a simulated treatment without therapeutic laser light. Both procedures began after the stitches were removed. Participants and a clinician rated scar quality 3 and 12 months after the last session.

Conditions

  • Traumatic Facial Wounds

Interventions

  • Photobiomodulation Therapy (PBMT)Device

    PBMT began after suture removal and was delivered using a 940 nm diode laser (Epic X, BIOLASE) set to 2 W in continuous-wave mode. The nominal beam diameter was 3 cm, corresponding to a spot area of approximately 7.1 cm² and an irradiance of approximately 0.28 W/cm². Each site was exposed for 20 seconds, corresponding to 40 J per site and a calculated radiant exposure of approximately 5.6 J/cm². The transparent handpiece attachment rested against the skin during application. Ten sessions were scheduled at three sessions per week.

  • Sham Photobiomodulation TherapyDevice

    The sham procedure began after suture removal and used the same device, handpiece, and application sites as active PBMT, with 20 seconds per site. The footswitch was not pressed, so no therapeutic laser light was emitted. Ten sessions were scheduled at three sessions per week.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Scar Quality Assessed by POSASTime frame: 3 months and 12 months after completion of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Oral and Maxillofacial Surgery, College of Dentistry, The Islamic University, Najaf, Iraq

    Kufa, Najaf, Iraq

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.